# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA616684 | B | Ability to displace [3H]-8-OH-DPAT from rat hippocampal homogenate 5-hydroxytryptamine 1A receptor | 3 | tissue-based format | Scientific Literature | |||
2. | ALA617064 | F | Agonist activity at cloned human 5-hydroxytryptamine 2A receptor using [125I]DOI radioligand | 4 | assay format | Scientific Literature | |||
3. | ALA617069 | F | Antagonist activity at cloned human 5-hydroxytryptamine 2A receptor using [3H]ketanserin radioligand; Not tested | 2 | assay format | Scientific Literature | |||
4. | ALA617374 | F | Agonist activity at cloned human 5-hydroxytryptamine 2B receptor using [3H]5-HT radioligand | 4 | assay format | Scientific Literature | |||
5. | ALA617377 | F | Antagonist activity at cloned human 5-hydroxytryptamine 2B receptor using [3H]- rauwolscine radioligand; Not tested | 2 | assay format | Scientific Literature | |||
6. | ALA617108 | F | Effect on phosphoinositide hydrolysis in NIH 3T3 fibroblast 5-hydroxytryptamine 2A receptor | 3 | assay format | Scientific Literature | |||
7. | ALA617115 | B | Tested for its ability to activate phospholipase c by quantification of IP3 at cloned rat 5-hydroxytryptamine 2A receptor | 1 | single protein format | Scientific Literature | |||
8. | ALA617470 | B | Ability to displace [3H]ketanserin from rat cortical homogenate 5-hydroxytryptamine 2A receptor | 2 | assay format | Scientific Literature | |||
9. | ALA617655 | F | Effect on phosphoinositide hydrolysis in NIH 3T3 fibroblast 5-hydroxytryptamine 2C receptor | 4 | assay format | Scientific Literature | |||
10. | ALA617898 | F | Agonist activity at cloned human 5-hydroxytryptamine 2C receptor using [125I]DOI radioligand | 4 | assay format | Scientific Literature | |||
11. | ALA617902 | F | Antagonist activity at cloned human 5-hydroxytryptamine 2C receptor using [3H]mesulergine radioligand; Not tested | 2 | assay format | Scientific Literature | |||
12. | ALA619177 | B | Affinity against 5-hydroxytryptamine receptors in rat fundus model | 44 | assay format | Scientific Literature | |||
13. | ALA631963 | F | Log value of hallucinogenic activity was determined | Homo sapiens | 63 | organism-based format | Scientific Literature | ||
14. | ALA630100 | P | Partition coefficient (logP) | 1 | small-molecule physicochemical format | Scientific Literature | |||
15. | ALA696016 | F | Hallucinogenic activity i.e; ratio of effective dose of mescaline to the effective dose in human | Homo sapiens | 63 | organism-based format | Scientific Literature | ||
16. | ALA698275 | F | Compound was tested for the psychotropic effect in human (activity is expressed in mescaline unit) | Homo sapiens | 8 | organism-based format | Scientific Literature | ||
17. | ALA699011 | F | Psychotomimetic potency of compound relative to that of mescaline(Human potency of mescaline = 1 MU) | Homo sapiens | 2 | organism-based format | Scientific Literature | ||
18. | ALA700102 | F | Compound tested for hallucinogenic activity in humans was reported; Value reported in (A)= Mescaline units | Homo sapiens | 91 | organism-based format | Scientific Literature | ||
19. | ALA731141 | B | In vitro bovine plasma monoamine oxidase deamination with semicarbazide | 4 | cell-free format | Scientific Literature | |||
20. | ALA731142 | B | In vitro bovine plasma monoamine oxidase deamination without semicarbazide | 8 | cell-free format | Scientific Literature |